| Authors: |
Sutherland BA; 1 Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; 2 School of Medicine, Faculty of Health, University of Tasmania, Hobart, Australia., Fordsmann JC; 3 Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Martin C; 4 Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; 5 Department of Psychology, The University of Sheffield, Sheffield, UK., Neuhaus AA; 1 Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Witgen BM; 3 Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Piilgaard H; 3 Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Lønstrup M; 3 Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Couch Y; 1 Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Sibson NR; 4 Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Lauritzen M; 3 Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.; 6 Department of Clinical Neurophysiology, Glostrup Hospital, Glostrup, Denmark., Buchan AM; 1 Radcliffe Department of Medicine, University of Oxford, Oxford, UK. |
